Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
commercialization
3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald
• 19 Apr 2022
3:09
The development of human acellular vessels and its advantages
Alan Kypson
• 22 Mar 2022
3:03
Tangential Flow Depth Filtration in viral vector manufacturing
Rachel Legmann
• 27 Jan 2022
2:27
The importance of collaboration in cell and gene therapy development
Delara Motlagh
• 27 Jan 2022
2:27
Improving the scalability of advanced therapies
Delara Motlagh
• 27 Jan 2022
1:16
Collaborating with hospitals and industry in cell therapies
Cate Dyer
• 27 Jan 2022
3:19
Meeting the increasing demand for viral vectors
Rachel Legmann
• 27 Jan 2022
1:41
Strategies for large scale viral vector development
Rachel Legmann
• 27 Jan 2022
1:44
Key developments in the future of advanced therapies
Lavakumar Karyampudi
• 27 Jan 2022
4:29
Achieving operational excellence in CGT through automation
Sharon Brownlow
• 26 Jan 2022
1:29
CMC challenges in cell and gene therapy manufacturing
Michael Lehmicke
• 26 Jan 2022
5:12
Challenges in decentralized manufacturing systems
Greg Roumeliotis
• 26 Jan 2022
2:25
Challenges in manufacturing advanced therapies for researchers
Kurt Gielen
• 17 Nov 2021
3:37
Ensuring successful commercialization of advanced therapies
Kurt Gielen
• 17 Nov 2021
3:32
Overcoming hurdles associated with commercializing advanced therapies
Laura Niklason
• 23 Nov 2021
1:41
Developmental barriers to tissue engineered corneas
Mark Daniell
• 8 Nov 2021
1
2
Next